Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Assets Average (2020 - 2025)

Black Diamond Therapeutics' Assets Average history spans 4 years, with the latest figure at $150.4 million for Q4 2025.

  • For Q4 2025, Assets Average rose 15.43% year-over-year to $150.4 million; the TTM value through Dec 2025 reached $150.4 million, up 15.43%, while the annual FY2025 figure was $132.8 million, N/A changed from the prior year.
  • Assets Average reached $150.4 million in Q4 2025 per BDTX's latest filing, down from $162.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $321.5 million in Q1 2021 to a low of $130.3 million in Q4 2024.
  • Average Assets Average over 3 years is $196.8 million, with a median of $162.1 million recorded in 2025.
  • Peak YoY movement for Assets Average: rose 23.38% in 2021, then decreased 28.26% in 2025.
  • A 3-year view of Assets Average shows it stood at $281.0 million in 2021, then plummeted by 53.64% to $130.3 million in 2024, then rose by 15.43% to $150.4 million in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Assets Average are $150.4 million (Q4 2025), $162.1 million (Q3 2025), and $171.3 million (Q2 2025).